Vascular Biology |
From the Department of Medicine (M.K.C.N., J.W., E.C., B.-y.W., R.K.-C., A.I.-W., J.P.C.), Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, Calif.; and the Department of Cardiology (M.K.C.N.), Royal Prince Alfred Hospital, Sydney, NSW, Australia.
Correspondence to John P. Cooke, Falk Cardiovascular Research Center, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305-5406. E-mail john.cooke{at}stanford.edu
Objective An endothelial nicotinic acetylcholine receptor (nAChR) participates in atherogenesis and tumorigenesis by promoting neovascularization. To date, the mechanisms of nAChR-mediated angiogenesis and their relationship to angiogenic factors, eg, VEGF and bFGF, are unknown.
Methods and Results Nicotine induced dose-dependent human microvascular endothelial cell (HMVEC) migration, a key angiogenesis event, to an extent which was equivalent in magnitude to bFGF (10 ng/mL) but less than for VEGF (10 ng/mL). Unexpectedly, nAChR antagonism not only abolished nicotine-induced HMVEC migration but also abolished migration induced by bFGF and attenuated migration induced by VEGF. Transcriptional profiling identified gene expression programs which were concordantly regulated by all 3 angiogens (nicotine, VEGF, and bFGF), a notable feature of which includes corepression of thioredoxin-interacting protein (TXNIP), endogenous inhibitor of the redox regulator thioredoxin. Furthermore, TXNIP repression by all 3 angiogens induced thioredoxin activity. Silencing thioredoxin by small interference RNA abrogated all angiogen-induced migration while silencing TXNIP strongly induced HMVEC migration. Interestingly, nAChR antagonism abrogates growth factor (VEGF and bFGF)mediated induction of thioredoxin activity.
Conclusions Nicotine promotes angiogenesis via stimulation of nAChR-dependent endothelial cell migration. Furthermore, growth factorinduced HMVEC migration, a key angiogenesis event, requires nAChR activationan effect mediated in part by nAChR-dependent regulation of thioredoxin activity.
Nicotine induces nicotinic acetylcholine receptor (nAChR)dependent endothelial cell migration (ECM). nAChR antagonism also suppresses bFGF- and VEGF-induced ECM. ECM induced by nicotine, VEGF, or bFGF requires nAChR-dependent induction of thioredoxin activity via repression of the thioredoxin inhibitor, TXNIP. Therefore growth factorinduced ECM, a key angiogenesis event, requires nAChR activation.
Key Words: nicotine angiogenesis endothelium vascular endothelial growth factor fibroblast growth factor
This article has been cited by other articles:
![]() |
D. S. Celermajer and M. K.C. Ng Where there's smoke... J. Am. Coll. Cardiol., May 6, 2008; 51(18): 1772 - 1774. [Full Text] [PDF] |
||||
![]() |
K. Kiuchi, M. Matsuoka, J. C. Wu, R. Lima e Silva, M. Kengatharan, M. Verghese, S. Ueno, K. Yokoi, N. H. Khu, J. P. Cooke, et al. Mecamylamine Suppresses Basal and Nicotine-Stimulated Choroidal Neovascularization Invest. Ophthalmol. Vis. Sci., April 1, 2008; 49(4): 1705 - 1711. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Sieveking, A. Buckle, D. S. Celermajer, and M. K.C. Ng Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. J. Am. Coll. Cardiol., February 12, 2008; 51(6): 660 - 668. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |